Grauer & Weil (India) Ltd Valuation Shifts Amid Market Pressure

Valuation Metrics and Market Context

As of 24 Feb 2026, Grauer & Weil’s price-to-earnings (P/E) ratio stands at 21.89, a figure that, while lower than some of its peers, still places the stock in the expensive category. The price-to-book value (P/BV) ratio is 3.08, signalling a premium valuation compared to the book value of its assets. These multiples have shifted from previously being classified as very expensive, indicating a slight correction in market pricing but still reflecting a valuation premium.

In comparison, industry heavyweights such as Navin Fluorine International and Himadri Speciality Chemicals maintain very expensive valuations with P/E ratios of 60.74 and 35.02 respectively, and EV/EBITDA multiples well above 25. Deepak Nitrite and Atul Chemicals, also in the expensive category, trade at P/E multiples of 40.54 and 32.24 respectively, underscoring the relative affordability of Grauer & Weil within its peer group despite its downgrade.

Mojo Grade Downgrade and Market Reaction

MarketsMOJO has downgraded Grauer & Weil’s Mojo Grade from Sell to Strong Sell as of 13 Oct 2025, reflecting deteriorating sentiment. The company’s Mojo Score currently stands at 23.0, a low figure that signals weak fundamentals and valuation concerns. The market cap grade remains modest at 3, indicating a relatively small market capitalisation compared to larger peers.

On the trading front, the stock closed at ₹67.70, down 2.11% from the previous close of ₹69.16. The 52-week high of ₹111.45 and low of ₹67.10 highlight significant volatility, with the current price hovering near the lower end of this range. Intraday trading on 24 Feb 2026 saw a high of ₹69.99 and a low of ₹67.10, underscoring investor caution amid valuation concerns.

Financial Performance and Returns Analysis

Grauer & Weil’s return profile over various periods presents a mixed picture. While the stock has delivered impressive long-term gains—467.71% over 10 years and 223.54% over 5 years—recent performance has lagged behind the benchmark Sensex. Year-to-date, the stock has declined by 9.03%, compared to a Sensex drop of 2.26%. Over the past year, the stock has underperformed significantly with a 24.69% loss against a 10.60% gain in the Sensex.

This divergence suggests that while the company has historically rewarded patient investors, near-term challenges and valuation pressures have weighed on sentiment. The return over three years remains positive at 43.20%, slightly ahead of the Sensex’s 39.74%, but the recent underperformance cannot be ignored.

Operational Efficiency and Profitability Metrics

Despite valuation concerns, Grauer & Weil demonstrates robust operational metrics. The company’s return on capital employed (ROCE) is a healthy 28.70%, indicating efficient use of capital to generate earnings. Return on equity (ROE) stands at 15.14%, reflecting reasonable profitability for shareholders.

Other valuation multiples such as EV to EBIT (18.66) and EV to EBITDA (15.89) suggest that the enterprise value remains elevated relative to earnings, consistent with the expensive valuation rating. The EV to capital employed ratio of 4.87 and EV to sales of 2.22 further reinforce the premium at which the stock trades.

Dividend yield remains modest at 0.74%, which may not be sufficiently attractive for income-focused investors, especially given the stock’s recent price weakness and valuation concerns.

Peer Comparison Highlights Valuation Disparities

Within the commodity chemicals sector, Grauer & Weil’s valuation is comparatively moderate but still expensive. Peers such as Aarti Industries, with a P/E of 43.49 but rated as fair value, and Fine Organic Chemicals, rated very expensive with a P/E of 36.35, illustrate the wide valuation spectrum in the sector.

Notably, some companies with higher P/E ratios maintain better PEG ratios, indicating growth expectations that may justify their valuations. Grauer & Weil’s PEG ratio is zero, signalling either a lack of meaningful earnings growth or insufficient data, which may contribute to investor scepticism.

These factors, combined with the downgrade to Strong Sell, suggest that investors should approach the stock with caution and consider valuation relative to growth prospects carefully.

Investment Implications and Outlook

The recent valuation downgrade and Strong Sell rating from MarketsMOJO reflect a cautious outlook on Grauer & Weil’s near-term prospects. While the company’s operational metrics remain solid, the premium valuation multiples and lack of evident growth catalysts weigh heavily on investor sentiment.

Investors should weigh the stock’s attractive long-term returns against its recent underperformance and valuation pressures. The stock’s proximity to its 52-week low and the negative returns over the past year suggest that downside risks remain significant.

Given the competitive landscape and availability of other commodity chemical stocks with more favourable valuations or growth prospects, Grauer & Weil may not currently represent the most compelling investment opportunity within the sector.

In summary, the shift from very expensive to expensive valuation, combined with a Strong Sell Mojo Grade and subdued price performance, signals that investors should exercise caution and consider alternative options before committing capital to Grauer & Weil at current levels.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →